Alerts will be sent to your verified email
Verify Email
MOREPENLAB
|
Morepen Laboratories
|
Solara Active Pharma
|
Aarti Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
API Sector
|
|||
|
Global DMFs filed
|
211.0 . | n/a | n/a |
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.87 % | n/a | 0.79 % |
|
Financials
|
|||
|
5 yr Average ROE
|
13.75 % | -8.31 % | 19.9 % |
|
5yr average Equity Multiplier
|
1.84 | 1.98 | 2.08 |
|
5yr Average Asset Turnover Ratio
|
1.34 | 0.55 | 1.13 |
|
5yr Avg Net Profit Margin
|
5.42 % | -5.56 % | 8.4 % |
|
Price to Book
|
2.44 | 2.35 | 2.45 |
|
P/E
|
21.53 | 0.0 | 20.48 |
|
5yr Avg Cash Conversion Cycle
|
21.38 Days | 115.03 Days | 82.62 Days |
|
Inventory Days
|
53.55 Days | 106.31 Days | 66.37 Days |
|
Days Receivable
|
63.5 Days | 125.38 Days | 113.27 Days |
|
Days Payable
|
98.41 Days | 142.19 Days | 95.33 Days |
|
5yr Average Interest Coverage Ratio
|
39.33 | 0.55 | 9.51 |
|
5yr Avg ROCE
|
15.84 % | 3.01 % | 22.85 % |
|
5yr Avg Operating Profit Margin
|
8.37 % | 10.34 % | 14.52 % |
|
5 yr average Debt to Equity
|
0.04 | 0.69 | 0.49 |
|
5yr CAGR Net Profit
|
23.42 % | n/a | 3.93 % |
|
5yr Average Return on Assets
|
7.36 % | -2.61 % | 9.61 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
35.65 % | 37.23 % | 55.38 % |
|
Share Pledged by Promoters
|
0.0 | 40.74 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.11 % | -2.28 % | -4.61 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -3.57 % | 5.58 % |
|
Morepen Laboratories
|
Solara Active Pharma
|
Aarti Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|